There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Anavex Life Sciences (AVXL – Research Report) and OncoCyte (OCX – Research Report) with bullish sentiments. Anavex Life Sciences (AVXL) BTIG analyst Yun Zhong reiterated a Buy rating on Anavex Life Sciences yesterday and set a price target of $35.00. The company's shares closed last Wednesday at $7.31, close to its 52-week low of $7.23. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-anavex-life-sciences-avxl-and-oncocyte-ocx?utm_source=advfn.com&utm_medium=referral
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Anavex Life Sciences Charts.
Anavex Life Sciences (NASDAQ:AVXL)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Anavex Life Sciences Charts.